THE DAILY BS: HOW MUCH CAN YOU HANDLE?
SPARE ME THE BS (I’ve got things to do).
- A minimally invasive knee treatment produced meaningful pain relief in 80% of patients evaluated at the one-year mark.
- The study involved 194 arthritis patients undergoing a procedure that uses tiny, dissolvable particles to block abnormal blood vessels around the knee.
- Median pain scores dropped from 7 to 3 on a 10-point scale, with no moderate or severe complications reported.
LAY IT ON ME (I’ve got time).
For millions of Americans whose knees have been complaining louder than their spouses, researchers may have some very welcome news.
A treatment that doesn’t involve replacing the knee, installing an artificial joint or undergoing major surgery has delivered encouraging results in patients suffering from painful osteoarthritis.
And here’s the number that’s getting everyone’s attention: 80% of patients evaluated after one year experienced clinically meaningful pain relief.
A non-surgical procedure that temporarily blocks excess blood vessels in the knee is delivering lasting pain relief for osteoarthritis patients — and 80% of participants in a new clinical study reported significant reductions in knee pain that held for at least a full year.
The treatment, called genicular artery embolization (GAE), uses microscopic gelatin particles to clog unnecessary blood vessels that grow around arthritic knees, fueling inflammation and irritating nerves.
Researchers say GAE could fill a critical gap for millions of adults whose pain medications and steroid injections have stopped working but who aren’t ready — or eligible — for a total knee replacement.
Full story here https://t.co/juxOxePeSN
— Fox News Health (@foxnewshealth) October 23, 2026
Researchers at Charité University Medicine Berlin studied 194 patients who underwent a procedure known as genicular artery embolization, or GAE.
The treatment involves inserting a thin catheter into blood vessels surrounding the knee and injecting microscopic gelatin particles that temporarily block abnormal vessels contributing to inflammation and pain.
The particles dissolve within hours. No artificial knee. No permanent implant.
The researchers performed 239 procedures because some patients received treatment in both knees.
Patients entered the study reporting a median pain score of 7 out of 10. Six weeks after treatment, that number had fallen to 4. By six months, it had dropped to 3, where it remained at the one-year follow-up.
And the improvements went beyond pain relief. Patients reported better mobility, easier daily activities, and improvements in recreation and overall quality of life.
In other words, things many people take for granted — walking comfortably, climbing stairs or simply getting out of a chair — became easier.
The median age of participants was 69, making the findings particularly interesting for older Americans who aren’t eager to schedule knee replacement surgery.
“For many patients with knee osteoarthritis, there is a real treatment gap today,” said Dr. Florian Nima Fleckenstein, deputy head of interventional radiology at Charité.
He explained that conventional treatments, including injections, sometimes stop providing sufficient relief even when joint replacement remains medically unsuitable or personally undesirable.
The new technique targets a different source of the problem. Osteoarthritis damages cartilage, but the condition also encourages abnormal blood vessels to develop around the knee joint. Those vessels contribute to inflammation and irritation of pain-sensitive nerves.
Rather than replacing the damaged joint, doctors interrupt that inflammatory process. The safety results were another encouraging development.
Across all 239 procedures, researchers reported no moderate or severe adverse events. Mild complications, including temporary skin discoloration and bruising, resolved without lasting problems.
There are still questions to answer. The study did not include a placebo comparison group, and researchers have only tracked the results for 12 months. The procedure also does not rebuild damaged cartilage or cure arthritis.
But additional research is adding to the interest. A separate randomized study published in Clinical Radiology found greater one-year pain improvement among patients receiving GAE than among those receiving standard management.
For people who have spent years choosing between another round of injections and the prospect of knee replacement surgery, the possibility of a third option is certainly worth watching.
The next question is whether larger trials can establish just how long the benefits last — and which patients stand to gain the most.
DBS WIRE SOURCES (I’ve got all day).
- Fox News — Knee treatment without surgery offers lasting pain relief
- Radiological Society of North America — Nonsurgical procedure provides lasting relief
- Radiology / PubMed — Original clinical study
- Clinical Radiology / PubMed — Separate randomized study
